Table 3.
Treatment | VXa | Paraoxonb | Sarinc | Tabund | ||||
---|---|---|---|---|---|---|---|---|
Protective Index (95% conf. limits) |
MDP | Protective Index (95% conf. limits) |
MDP | Protective Index (95% conf. limits) |
MDP | Protective Index (95% conf. limits) |
MDP | |
Therapy | 5.0 (2.2–11.7) |
3.2 | 10 (7.5–13.3) |
6.3 | 2.9 (2.3–3.7) |
2.0 | 1.6 (1.2–2.1) |
1.3 |
Pretreatment + Therapy |
5.0 (3.3–7.7) |
3.2 | 16 (13.5–18.7) |
13 | 4.0 (2.5–6.4) |
2.0 | 1.3 (1.0–1.6) |
1.3 |
s.c. LD50 of VX was 28 µg/kg.
s.c. LD50 of Paraoxon was 740 µg/kg.
s.c. LD50 of Sarin was 240 µg/kg.
s.c. LD50 of Tabun was 570 µg/kg.